RA
Rosalind Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79M | Buy |
700,000
+105,000
| +18% | +$1.47M | 4.64% | 7 |
|
|
2025
Q1 | $8.02M | Buy |
+595,000
| New | +$8.02M | 3.9% | 11 |
|
|
2024
Q3 | – | Sell |
-300,000
| Closed | -$3.9M | – | 40 |
|
|
2024
Q2 | $3.9M | Hold |
300,000
| – | – | 3% | 16 |
|
|
2024
Q1 | $5.25M | Sell |
300,000
-60,332
| -17% | -$1.06M | 4.91% | 9 |
|
|
2023
Q4 | $7.85M | Buy |
+360,332
| New | +$7.85M | 6.46% | 5 |
|